Related Experiment Video
Updated: Jul 6, 2025

09:02
A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
4.5K
Rhabdomyolysis-Induced Acute Kidney Injury Treated with Medium Cut-Off Membrane: A Case Report
Girish V Kumthekar1, Urvi Shukla2, Veena Purandare3
1Department of Nephrology, Symbiosis University Hospital and Research Center (SUHRC), Symbiosis Medical College for Women (SMCW), Symbiosis International University (SIU), Lavale, Pune, Maharashtra, India.
Indian Journal of Nephrology
|January 4, 2024
Summary
This study highlights a novel treatment for rhabdomyolysis-induced acute kidney injury. Medium cut-off membrane dialysis effectively removed myoglobin, aiding renal recovery in a severe case.
Area of Science:
- Nephrology
- Toxicology
- Intensive Care Medicine
Background:
- Acute kidney injury (AKI) is a common complication of rhabdomyolysis, occurring in 10-40% of patients.
- Diagnosis relies on myoglobinuria and elevated creatine kinase (CK).
- Intermittent hemodialysis is a treatment option for rhabdomyolysis with azotemia or oliguria.
Observation:
- A 31-year-old male presented with severe lower limb pain, hypertension, elevated creatinine (15.7 mg/dL), and extremely high CK levels (>20,000 IU/L) after extensive exercise.
- Initial intermittent hemodialysis was insufficient, and the patient developed posterior reversible encephalopathy syndrome and seizures.
- A further increase in CK levels was noted despite conventional treatment.
Findings:
- Extracorporeal removal of myoglobin using a medium cut-off (MCO) membrane was initiated.
- Three sessions with the MCO membrane led to significant reductions in myoglobin and CK levels.
- The patient was successfully transitioned to conventional dialysis and discharged with complete renal recovery.
Implications:
- Medium cut-off membrane technology offers an effective method for myoglobin clearance in severe rhabdomyolysis-induced AKI.
- This approach achieves significant reduction in myoglobin and CK without substantial albumin loss.
- MCO membrane dialysis presents a potentially cost-effective and efficient therapeutic option for managing this critical condition.

